New CNS Drugs For Treating Psychiatric And neurological disorders By Taj Pharma

Top Quote Launch of new Life Saving Drugs for Treating Psychiatric and neurological disorders by India Based Pharmaceuticals Company. End Quote
  • (1888PressRelease) April 07, 2011 - India based pharmaceuticals company Taj Pharmaceuticals Ltd. Announced the manufacturing of new CNS Drugs for Treating Psychiatric and neurological disorders and is dedicated to the development of 5 new pharmaceuticals drugs for the treatment of diseases related to the Central Nervous System. The drugs will be marked and manufactured under the Life Saving Drugs division of the company.

    The company's CEO Abhishek Kr. Singh announced the launch of Six (6) New CNS Drug at Taj Resorts and Place Hotel, Mumbai, India. The new formulation and brands will be launched in all the current international markets specially Middle East countries.

    The announced brands and formulations are as follows:
    Mebrasil® CIV (brand of mephobarbital tablets, USP)
    Rematal® CII Sodium Solution (pentobarbital sodium injection, USP)
    Pegarin® (ethotoin tablets, USP)
    Vegarin® (vigabatrin) Tablets & Oral Solution
    Zepran® CIV (clorazepate dipotassium)
    Tetrazin ® (tetrabenazine) Tablets

    By this launch Taj Pharmaceuticals, focuses is on providing severely ill patient populations with innovative and effective therapies that satisfy unmet medical needs. The medicine will be available for conditions such as Acute Intermittent Porphyria etc.

    Mr. Singh also mentioned about the subsidised marketing plans for the above mentioned drugs and the company's focus will be minimum on the financial gains by this launch. Although the announcement led the increase in the stock value of the company in the internal stock exchanges.


    Taj Pharmaceuticals Limited is known as a pharmaceuticals manufacturing company found and based in India. The company manufacturer's pharmaceuticals formulations and API for India and other countries. The company was established in 1995 as an enterprise and in 2004 became a public limited company. As per Mumbai pharmaxil and Chemixil association the company manufacturers and exports to countries like Iran, Iraq and Asia Pacific. In recent EU-Indonesia Business Dialogue (EIBD) conference Taj Pharma Group was listed amongst top 10 pharmaceutical companies in EU by 2008 sales.

  • FB Icon Twitter Icon In-Icon
Contact Information